
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Imaging, Diagnosis, Prognosis |
Authors' Affiliations: 1 Department of Pathology, University of Massachusetts School of Medicine, Worchester, Massachusetts; Departments of 2 Pathology and 3 Dermatology, and 4 Yale Cancer Center, Yale University School of Medicine, New Haven, Connecticut
Requests for reprints: John M. Pawelek, Department of Dermatology, Yale University School of Medicine, 333 Cedar Street, New Haven, CT 06520-8059. Phone: 203-785-4411; Fax: 203-785-7637; E-mail: john.pawelek{at}yale.edu.
Purpose: This study was designed to provide a comprehensive assessment on the role of ß1,6-branched oligosaccharides in the metastasis and outcome of breast carcinoma. Generation of these structures on N-glycans is initiated by ß1,6-N-acetylglucosaminyltransferase V and used by both myeloid cells and cancer cells in systemic migration.
Experimental Design: Tissue microarrays of >700 tumors (>400 patients; 30-year follow-up data) were stained through lectin histochemistry with leukocytic phytohemagglutinin (LPHA), a selective marker for ß1,6-branched oligosaccharides. Node-negative and node-positive primary tumors and patient-matched lymph node metastases were scored by blinded observers.
Results: Metastases stained at significantly greater intensities than did the patient-matched primary tumors (P < 0.0001), demonstrating for the first time that the abundance of ß1,6-branched oligosaccharides was directly associated with breast carcinoma nodal metastasis. Multivariate analyses revealed that ß1,6-branched oligosaccharides in primary tumors were a predictor of poor outcome, most notably in node-negative tumors, where an LPHA staining score of 3+ gave a risk factor of 3.3, independent of tumor size, nuclear grade, or patient age (P = 0.007).
Conclusions: The data firmly establish a role for ß1,6-N-acetylglucosaminyltransferase V activity and ß1,6-branched oligosaccharides in breast carcinoma metastasis, and reemphasize the involvement, although poorly understood, of aberrant glycosylation in tumor progression.
Key Words: N-glycosylation GnT-V tumor progression Kaplan-Meier analyses vesicular phenotype
This article has been cited by other articles:
![]() |
H.-B. Guo, H. Johnson, M. Randolph, I. Lee, and M. Pierce Knockdown of GnT-Va expression inhibits ligand-induced downregulation of the epidermal growth factor receptor and intracellular signaling by inhibiting receptor endocytosis Glycobiology, May 1, 2009; 19(5): 547 - 559. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wei and L. Li Comparative glycoproteomics: approaches and applications Brief Funct Genomic Proteomic, March 1, 2009; 8(2): 104 - 113. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Kyselova, Y. Mechref, P. Kang, J. A. Goetz, L. E. Dobrolecki, G. W. Sledge, L. Schnaper, R. J. Hickey, L. H. Malkas, and M. V. Novotny Breast Cancer Diagnosis and Prognosis through Quantitative Measurements of Serum Glycan Profiles Clin. Chem., July 1, 2008; 54(7): 1166 - 1175. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Li, Y. Li, X. Wu, Q. Li, J. Yu, J. Gen, and X.-L. Zhang Knockdown of Mgat5 Inhibits Breast Cancer Cell Growth with Activation of CD4+ T Cells and Macrophages J. Immunol., March 1, 2008; 180(5): 3158 - 3165. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. H.M. de Melo, D. Butera, R. S. Medeiros, L. N. d. S. Andrade, S. Nonogaki, F. A. Soares, R. A. Alvarez, A. M. Moura da Silva, and R. Chammas Biological Applications of a Chimeric Probe for the Assessment of Galectin-3 Ligands J. Histochem. Cytochem., October 1, 2007; 55(10): 1015 - 1026. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-B. Guo, M. Randolph, and M. Pierce Inhibition of a Specific N-Glycosylation Activity Results in Attenuation of Breast Carcinoma Cell Invasiveness-related Phenotypes: INHIBITION OF EPIDERMAL GROWTH FACTOR-INDUCED DEPHOSPHORYLATION OF FOCAL ADHESION KINASE J. Biol. Chem., July 27, 2007; 282(30): 22150 - 22162. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. R. Drake, E. E. Schwegler, G. Malik, J. Diaz, T. Block, A. Mehta, and O. J. Semmes Lectin Capture Strategies Combined with Mass Spectrometry for the Discovery of Serum Glycoprotein Biomarkers Mol. Cell. Proteomics, October 1, 2006; 5(10): 1957 - 1967. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. F. Siddiqui, J. Pawelek, T. Handerson, C.-Y. Lin, R. B. Dickson, D. L. Rimm, and R. L. Camp Coexpression of {beta}1,6-N-Acetylglucosaminyltransferase V Glycoprotein Substrates Defines Aggressive Breast Cancers with Poor Outcome Cancer Epidemiol. Biomarkers Prev., November 1, 2005; 14(11): 2517 - 2523. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |